Form D · Manufacturing
BIOVITTORIA LTD
Hamilton, Q2 · CIK 0001450873
Offering snapshot reported Apr 29, 2010 · SEC filing
- Reported sold
- $265K Offering amount: $265K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 26, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2010 | Initial | $265,000 | No comparison | 5 | SEC filing |
| Sep 16, 2009 | Amendment | $350,000 | No comparison | 2 | SEC filing |
| Nov 18, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-141297
Issuer is based in New Zealand. Issuer has raised an additional US$899,704 from 18 investors outside the United States.
First ranking preference shares
Source: Form D, filed Apr 29, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Robert Le Febvre | Director, Executive |
| Bridget Liddell | Director |
| Stuart Andrew Mc Kenzie | Director |
| Dr Garth Selwyn Smith | Director, Executive |
| Robert Stringer | Director, Executive |
| David Timothy Thorrold | Director, Executive |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
Waikato Innovation Park Ruakura Road
Hamilton, Q2, NONE
Hamilton, Q2, NONE